FGF23 is endogenously phosphorylated in bone cells

Journal of Bone and Mineral Research

Volumn 30, Issue 3, 2015, Pages 431-436

  Lindberg, Iris ^a   Pang, Hong Weng ^a   Stains, Joseph P ^a   Clark, David ^a   Yang, Austin J ^a   Bonewald, Lynda ^b   Li, Kevin Z ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone; FAM20C; FGF23; Kinase; Osteocyte; Phosphate Homeostasis

Indexed keywords

ALANINE; ANTIBODY; FAM20C KINASE; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PHOSPHOPEPTIDE; PHOSPHOTRANSFERASE; PROTEIN; RECOMBINANT PROTEIN; SERINE; SIBLING PROTEIN; UNCLASSIFIED DRUG; FIBROBLAST GROWTH FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BONE CELL; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; GLYCOSYLATION; GOLGI COMPLEX; HEK293 CELL LINE; HUMAN; HUMAN CELL; IDG SW3 CELL LINE; IMMUNOREACTIVITY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LONG BONE; MASS SPECTROMETRY; OSTEOCYTE; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS; ANIMAL; BONE; CHEMISTRY; CYTOLOGY; METABOLISM; MOUSE; PHOSPHORYLATION;

ANIMALS; BONE AND BONES; CELL LINE; FIBROBLAST GROWTH FACTORS; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION;

EID: 84922913224     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2354     Document Type: Article

References (22)

1. Liu S, Tang W, Fang J, et al. Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol. 2009;23(9): 1505-18.
2. Christov M, Juppner H. Insights from genetic disorders of phosphate homeostasis. Semin Nephrol. 2013;33(2): 143-57.
3. Goetz R, Nakada Y, Hu MC, et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA. 2010;107(1): 407-12.
4. Bergwitz C, Banerjee S, Abu-Zahra H, et al. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab. 2009;94(11): 4267-74.
5. Gram Schjoldager KT, Vester-Christensen MB, Goth CK, et al. A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing. J Biol Chem. 2011; 286(46): 40122-32.
6. Kato K, Jeanneau C, Tarp MA, et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem. 2006;281(27): 18370-7.
7. Yuan B, Feng JQ, Bowman S, et al. Hexa-D-arginine treatment increases 7B2-PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res. 2013;28(1): 56-72.
8. Benet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM. FGF23 is processed by proprotein convertases but not by PHEX. Bone. 2004;35(2): 455-62.
9. Tagliabracci VS, Engel JL, Wen J, et al. Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science. 2012; 336(6085): 1150-3.
10. Ishikawa HO, Xu A, Ogura E, Manning G, Irvine KD. The Raine syndrome protein FAM20C is a Golgi kinase that phosphorylates biomineralization proteins. PLoS One. 2012;7(8): E42988.
11. Ichikawa S, Lyles KW, Econs MJ. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: Evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab. 2005;90(4): 2420-3.
12. Larsson T, Davis SI, Garringer HJ, et al. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology. 2005;146(9): 3883-91.
13. Wang X, Hao J, Xie Y, et al. Expression of FAM20C in the osteogenesis and odontogenesis of mouse. J Histochem Cytochem. 2010;58(11): 957-67.
14. Rafaelsen SH, Raeder H, Fagerheim AK, et al. Exome sequencing reveals FAM20c mutations associated with FGF23-related hypophosphatemia, dental anomalies and ectopic calcification. J Bone Miner Res. 2013;28(6): 1378-85.
15. Bennett HPJ, Browne CA, Solomon S. Biosynthesis of phosphorylated forms of corticotropin-related peptides Proc Natl Acad Sci USA. 1981; 78(8): 4713-7.
16. D'Souza NB, Lindberg I. Evidence for the phosphorylation of a proenkephalin-derived peptide, peptide B. J Biol Chem. 1988;263(5): 2548-52.
17. Watkinson A, Dockray GJ, Young J, Gregory H. Proenkephalin A processing in the upper digestive tract: Isolation and characterisation of phosphorylated N-terminally extended Met-enkephalin Arg6Phe7 variants. J Neurochem. 1988;51(4): 1252-7.
18. Thibault G, Lazure C, Chretien M, Cantin M. Molecular heterogeneity of pro-atrial natriuretic factor. J Biol Chem. 1989;264(31): 18796-02.
19. Rowe PS. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct. 2012;30(5): 355-75.
20. Woo SM, Rosser J, Dusevich V, Kalajzic I, Bonewald LF. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res 2011;26(11): 2634-46.
21. Garringer HJ, Malekpour M, Esteghamat F, et al. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab. 2008;295(4): E929-37.
22. Tagliabracci VS, Engel JL, Wiley SE, et al. Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosyltion, and furin proteolysis. Proc Natl Acad Sci USA. 2014;111(15): 5520-5.